IP Library › Assignment 026764/0070
Patent Assignment
Reel/Frame 026764/0070

Corrective Assignment to Correct the Assignor Name Previously Recorded on Reel 023915 Frame 0283. Assignor(S) Hereby Confirms the Correct Assignor Name Is Semafore Pharmaceuticals, Inc..

Recorded: 2011-08-17 Pages: 11
Assignor
SEMAFORE PHARMACEUTICALS, INC.
Executed: 2009-07-02
Assignee
PARK FUNDING, LLC
17338 WESTFIELD PARK ROAD, SUITE 3, WESTFIELD, INDIANA, 46074
Covered Properties (13)
PI3 Kinase Inhibitor Prodrugs
Pten Inhibitors
O-Alkylated Pi-3 Kinase Inhibitor Prodrug Combination
Pten Inhibitors
Application: 10/599,748 →
Publication: US 2007/0203098
Pi-3 Kinase Inhibitor Prodrugs
Patent: 6,949,537 →
Application: 10/818,145 →
Publication: US 2004/0242631
Pi-3 Kinase Inhibitor Prodrugs
Patent: 7,396,828 →
Application: 11/111,201 →
Publication: US 2005/0203173
Pi-3 Kinase Inhibitor Prodrugs
Patent: 7,662,977 →
Application: 11/962,612 →
Publication: US 2008/0188423
Targeted prodrugs of PI3 kinase inhibitors
Application: 60/460,137 →
PTEN inhibitors and compositions for therapeutic utility in treating disease in mammals
Application: 60/559,802 →
PTEN inhibitors for sensitization of cancer cells
Application: 60/590,043 →
PTEN inhibitors
Application: 60/625,871 →
O-Alkylated PI-3 Kinase Inhibitor Prodrugs
Application: 61/031,308 →
O-Alkylated Pi-3 Kinase Inhibitor Prodrug Combination
Application: 61/044,780 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement May 29, 2009
From: SEMAFORE PHARMACEUTICALS, INC.
To: PARK FUNDING, LLC
Reel/Frame 022746/0638 →
Assignment of Assignor's Interest Feb 9, 2010
From: SEMAPHORE PHARMACEUTICALS, INC.
To: PARK FUNDING, LLC
Reel/Frame 023915/0283 →
Assignment of Assignor's Interest Apr 29, 2013
From: PARK FUNDING, LLC
To: SIGNALRX PHARMACEUTICALS, INC.
Reel/Frame 030305/0819 →